Christopher A. Peters

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

Andre Esteva, Jean Feng, Douwe van der Wal et al. · npj Digital Medicine · 2022 · 197 citations · Full text

Medicine, Oncology, Urology +17

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial

Seth A. Rosenthal, Chen Hu, Oliver Sartor et al. · Journal of Clinical Oncology · 2019 · 153 citations · Full text

Medicine, Oncology, Urology +14

Long-term results of local recurrence after breast conservation treatment for invasive breast cancer

Todd Doyle, Delray J. Schultz, Christopher A. Peters et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 133 citations

Medicine, Oncology, Surgery +17

Association of Single Nucleotide Polymorphisms in<i>SOD2, XRCC1</i>and<i>XRCC3</i>with Susceptibility for the Development of Adverse Effects Resulting from Radiotherapy for Prostate Cancer

Ryan J. Burri, Richard G. Stock, Jamie A. Cesaretti et al. · Radiation Research · 2008 · 87 citations

Medicine, Genetics, Oncology +17

TGFB1 Single Nucleotide Polymorphisms Are Associated With Adverse Quality of Life in Prostate Cancer Patients Treated With Radiotherapy

Christopher A. Peters, Richard G. Stock, Jamie A. Cesaretti et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 69 citations

Medicine, Oncology, Radiation Oncology +11